Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: Impact of HLA class I antigen expression on outcome
Jeffrey A. Sosman*, Joseph M. Unger, P. Y. Liu, Lawrence E. Flaherty, Min S. Park, Raymond A. Kempf, John A. Thompson, Paul I. Terasaki, Vernon K. Sondak
Dive into the research topics of 'Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: Impact of HLA class I antigen expression on outcome'. Together they form a unique fingerprint.